![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Leukemia |
Free Subscription
3 Am J Hematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
Breaking the Bone Marrow Barrier: Peripheral Blood as a Gateway to Measurable
Residual Disease Detection in Acute Myelogenous Leukemia.
Am J Hematol. 2025 Jan 7. doi: 10.1002/ajh.27586.
PubMed
Abstract available
Hyper-CVAD and Sequential Blinatumomab Without and With Inotuzumab in Young
Adults With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute
Lymphoblastic Leukemia.
Am J Hematol. 2025 Jan 5. doi: 10.1002/ajh.27576.
PubMed
Abstract available
Characteristics and clinical outcomes of patients with myeloid malignancies and
DDX41 variants.
Am J Hematol. 2023;98:1780-1790.
PubMed
Abstract available
DNMT3A-R882: a mutation with many paradoxes.
Ann Hematol. 2024;103:4981-4988.
PubMed
Abstract available
Prognostic significance of GATA2 in patients with MDS/AML: a systematic review
and meta-analysis.
Ann Hematol. 2024;103:4943-4952.
PubMed
Abstract available
Distinct clinical profiles and patient outcomes in aCML and CNL.
Ann Hematol. 2024;103:5325-5332.
PubMed
Abstract available
Intensification of upfront chemotherapy for patients with myeloid blast phase
CML: a single center experience.
Ann Hematol. 2024;103:5395-5403.
PubMed
Abstract available
Overall survival in TP53-mutated AML and MDS.
Ann Hematol. 2024;103:5359-5369.
PubMed
Abstract available
Prognostic significance of early nk cell recovery in pediatric t-cell replete
allogeneic hematopoietic stem cell transplantation.
Ann Hematol. 2024;103:5769-5780.
PubMed
Abstract available
Central nervous system relapse after allogeneic HCT in FLT3-mutated AML.
Ann Hematol. 2024;103:5387-5393.
PubMed
Abstract available
Construction of AML prognostic model with CYP2E1 and GALNT12 biomarkers based on
golgi- associated genes.
Ann Hematol. 2024;103:5297-5314.
PubMed
Abstract available
Pyoderma gangrenosum-like neutrophilic dermatosis as an adverse effect of
menin-KMT2A inhibitor therapy for acute myeloid leukaemia.
Ann Hematol. 2024;103:5985-5988.
PubMed
Abstract available
FLT3 inhibitors and hematopoietic cell transplantation prolong survival in
patients with FLT3-ITD-positive AML.
Ann Hematol. 2024;103:5333-5340.
PubMed
Abstract available
A fatal case of peritonitis due to colonic localization of acute myeloid
leukemia.
Ann Hematol. 2025 Jan 7. doi: 10.1007/s00277-024-06172.
PubMed
Abstract available
PEG-rhG-CSF versus rhG-CSF in supporting neutrophil recovery after induction
chemotherapy for patients with newly diagnosed acute lymphoblastic leukemia.
Ann Hematol. 2025 Jan 8. doi: 10.1007/s00277-025-06183.
PubMed
Abstract available
Prognosis of aggressive adult T-cell leukemia/lymphoma with central nervous
system infiltration and utility of CD7 versus CADM1 flowcytometric plots of
cerebrospinal fluid.
Ann Hematol. 2025 Jan 10. doi: 10.1007/s00277-025-06186.
PubMed
Abstract available
Sustained treatment-free remission in two chronic myeloid leukemia patients after
asciminib discontinuation: a report of two cases.
Ann Hematol. 2025 Jan 10. doi: 10.1007/s00277-024-06170.
PubMed
Abstract available
The efficacy and safety of nelarabine in relapsed or refractory T-cell acute
lymphoblastic leukemia: a systematic review and meta-analysis.
Ann Hematol. 2025 Jan 10. doi: 10.1007/s00277-024-06121.
PubMed
Abstract available
Outcomes in patients with acute myeloid leukemia older than 70 years within the
last 30 years, a single center experience.
Ann Hematol. 2025 Jan 11. doi: 10.1007/s00277-025-06196.
PubMed
Abstract available
Outcomes in patients with ETV6::RUNX1 or high-hyperdiploid B-ALL treated in the
St. Jude Total Therapy XV/XVI studies.
Blood. 2025;145:190-201.
PubMed
Abstract available
Targeting Senescent Stemlike Subpopulations in Philadelphia Chromosome-Like Acute
Lymphoblastic Leukemia.
Blood. 2025 Jan 7:blood.2024026482. doi: 10.1182/blood.2024026482.
PubMed
Abstract available
Genetic subtypes of B-cell acute lymphoblastic leukemia in adults.
Blood. 2024 Dec 30:blood.2023022919. doi: 10.1182/blood.2023022919.
PubMed
Abstract available
alpha-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid
leukemia.
Blood. 2024 Dec 27:blood.2024025245. doi: 10.1182/blood.2024025245.
PubMed
Abstract available
DNTT-mediated DNA Damage Response Drives Inotuzumab Ozogamicin Resistance in
B-cell Acute Lymphoblastic Leukemia.
Blood. 2024 Dec 27:blood.2024026085. doi: 10.1182/blood.2024026085.
PubMed
Abstract available
High-throughput drug screening identifies SMAC mimetics as enhancers of NK cell
cytotoxicity in chronic myeloid leukemia.
Blood. 2025 Jan 10:blood.2024025286. doi: 10.1182/blood.2024025286.
PubMed
Abstract available
Molecular measurable residual disease before transplantation independently
predicts survival and relapse risk in adult lysine methyltransferase
2a-rearranged acute myeloid leukemia.
Cancer. 2025;131:e35717.
PubMed
Abstract available
FLT3 inhibitors induce p53 instability, driven by STAT5/MDM2/p53 competitive
interactions in acute myeloid leukemia.
Cancer Lett. 2025;611:217446.
PubMed
Abstract available
Hyper-CVAD and Modified CALGB-10403 Regimens in Adult Patients With
Philadelphia-Negative Acute Lymphoblastic Leukemia: A Comparative Study.
Eur J Haematol. 2025 Jan 7. doi: 10.1111/ejh.14381.
PubMed
Abstract available
Advances and Challenges in Quizartinib-Based FLT3 Inhibition for Acute Myeloid
Leukemia: Mechanisms of Resistance and Prospective Combination Therapies.
Eur J Haematol. 2025 Jan 6. doi: 10.1111/ejh.14383.
PubMed
Abstract available
Outcomes of Elderly Patients Admitted to the Intensive Care Unit for Newly
Diagnosed Acute Myeloid Leukemia.
Eur J Haematol. 2025 Jan 6. doi: 10.1111/ejh.14366.
PubMed
Abstract available
Inferior Overall Survival After Haploidentical Donor Lymphocyte Infusions in
Relapsed Myeloid Neoplasms.
Eur J Haematol. 2025;114:315-324.
PubMed
Abstract available
Impact of TP53 Mutation Status in Elderly AML Patients When Adding All-Trans
Retinoic Acid or Valproic Acid to Decitabine.
Eur J Haematol. 2025;114:231-237.
PubMed
Abstract available
A Distinct Alternative mRNA Splicing Profile Identifies the Oncogenic CD44
Transcript Variant 3 in KMT2A-Rearranged Pediatric T-cell Acute Lymphoblastic
Leukemia Cells.
Exp Hematol. 2025 Jan 8:104712. doi: 10.1016/j.exphem.2025.104712.
PubMed
Abstract available
ARF3 as a novel biomarker and target in acute myeloid leukemia: Insights from
pan-cancer analysis.
Genomics. 2025 Jan 3:110984. doi: 10.1016/j.ygeno.2024.110984.
PubMed
Abstract available
The acetylglucosaminyltransferase GnT-? regulates erythroid differentiation
through ERK/MAPK signaling.
J Biol Chem. 2024;300:108010.
PubMed
Abstract available
Randomized Phase III SIERRA Trial of (131)I-Apamistamab Before Allogeneic
Hematopoietic Cell Transplantation Versus Conventional Care for
Relapsed/Refractory AML.
J Clin Oncol. 2025;43:201-213.
PubMed
Abstract available
A Survey of Sedation Practices for Adolescents and Young Adults With Acute
Lymphoblastic Leukemia Undergoing Lumbar Puncture.
J Pediatr Hematol Oncol. 2025 Jan 10. doi: 10.1097/MPH.0000000000002983.
PubMed
Abstract available
A Neonate Presenting With Large Abdominal Mass: A Rare Case of Congenital
Leukemia.
J Pediatr Hematol Oncol. 2025 Jan 8. doi: 10.1097/MPH.0000000000002991.
PubMed
Abstract available
Clonorchiasis, Marked Eosinophilia, and the Lack of Blasts in the Circulation
Delaying the Diagnosis of Pediatric B-Lymphocytic Leukemia.
J Pediatr Hematol Oncol. 2025 Jan 6. doi: 10.1097/MPH.0000000000002989.
PubMed
Abstract available
Comparison of Capizzi and High-dose Methotrexate Approaches in the Treatment of
Pediatric B-cell Acute Lymphoblastic Leukemia.
J Pediatr Hematol Oncol. 2025 Jan 6. doi: 10.1097/MPH.0000000000002995.
PubMed
Abstract available
Frontline immunotherapeutic combination strategies in adult B-cell acute
lymphoblastic leukemia: reducing chemotherapy intensity and toxicity and
harnessing efficacy.
Leuk Lymphoma. 2025 Jan 10:1-12. doi: 10.1080/10428194.2025.2449582.
PubMed
Abstract available
A novel prognostic risk model for patients with refractory/relapsed acute myeloid
leukemia receiving venetoclax plus hypomethylating agents.
Leukemia. 2025 Jan 8. doi: 10.1038/s41375-024-02501.
PubMed
Abstract available
NPM1-fusion proteins promote myeloid leukemogenesis through XPO1-dependent HOX
activation.
Leukemia. 2025;39:75-86.
PubMed
Abstract available
CD36 cell surface expression as a surrogate marker to identify ABL/JAK-class
kinase fusions in pediatric BCP-ALL.
Leukemia. 2025;39:64-74.
PubMed
Abstract available
Monitoring clonal burden as an alternative to blast count for myelodysplastic
neoplasm treatment response.
Leukemia. 2025;39:166-177.
PubMed
Abstract available
The epigenetic state of the cell of origin defines mechanisms of leukemogenesis.
Leukemia. 2025;39:87-97.
PubMed
Abstract available
Sex-dependent differences in hematopoietic stem cell aging and leukemogenic
potential.
Oncogene. 2024 Nov 1. doi: 10.1038/s41388-024-03197.
PubMed
Abstract available
Thank you for your interest in scientific medicine.